← Leaderboards
Michael James Haller
University Of Florida
$2,433,805
Attributed
$3,709,721
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $675.8K · FY2008–24$1M$750K$500K$250K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$3,709,721 · 3
By mechanism
R01$2,551,832 · 1
U01$675,801 · 1
R21$482,088 · 1
Top collaborators
- Martha L Campbell-Thompson4 shared
Most similar at University Of Florida
Same institution · by research overlap
- Mark A Atkinson$38,540,675
- Lyle L Moldawer$27,709,476
- Martha L Campbell-Thompson$8,691,417
- Benjamin George Keselowsky$10,555,340
- Gilbert Rivers Upchurch$11,289,054
Others in their field
Top investigators on “Glycosylated Hemoglobin A”
- John M Lachin · George Washington University$134,552,372
- David M Nathan · Massachusetts Institute Of Technology$122,159,340
- Rose A Gubitosi-Klug · Case Western Reserve University$60,881,424
- Rohit Varma · University Of Southern California$43,479,151
- Anastassios G Pittas · Tufts Medical Center$32,774,287
- Ziad Nahas · Medical University Of South Carolina$22,722,368
Research focus
Glycosylated Hemoglobin AChildInsulinAffectC-PeptideNatural HistoryEnrollmentImmunologicsCell PhysiologyAutoimmunityPancreasResponseDiabetes MellitusAutoantibodiesDisease ProgressionDisorder RiskEventInsulin-Dependent Diabetes MellitusCellsIslets Of LangerhansCustomAbdomenBeta CellArginine
Grant awards (8)
Understanding pancreatic endocrine and exocrine loss in pre-type 1 diabetes$615,410
R01 · FY2024 · DK
Understanding pancreatic endocrine and exocrine loss in pre-type 1 diabetes$641,052
R01 · FY2023 · DK
Understanding pancreatic endocrine and exocrine loss in pre-type 1 diabetes$641,052
R01 · FY2021 · DK
Understanding pancreatic endocrine and exocrine loss in pre-type 1 diabetes$654,318
R01 · FY2020 · DK
TrialNet: University of Florida Clinical Center and Network$675,801
U01 · FY2018 · DK · contact PI
Short Course G-CSF as Immunomodulatory Therapy for Type 1 Diabetes ? A Pilot Stud$85,500
R21 · FY2010 · DK · contact PI
Short Course G-CSF as Immunomodulatory Therapy for Type 1 Diabetes ? A Pilot Stud$198,321
R21 · FY2009 · DK · contact PI
Short Course G-CSF as Immunomodulatory Therapy for Type 1 Diabetes ? A Pilot Stud$198,267
R21 · FY2008 · DK · contact PI